Immunovant Inc. Common Stock vs Ovintiv Inc. (DE) — how do they compare? Immunovant Inc. Common Stock trades at $30.33 (market cap $6.25B), while Ovintiv Inc. (DE) trades at $64.16 (market cap $17.53B). The key difference: Ovintiv Inc. (DE) is far larger — about 2.8× Immunovant Inc. Common Stock's market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Ovintiv Inc. (DE) for 0 Days on average.
| IMVT | OVV | |
|---|---|---|
Market Cap | $6.25B | $17.53B |
Volume | 1,755,411 | 3,002,714 |
Sector | Health | Energy |
52-Week High | $44.96 | $66.97 |
52-Week Low | $17.03 | $35.97 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $21.86B |
Dividend Yield | — | 1.89% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →